Data study · analyzed July 2026
State of the Peptide Community 2026
We classified 2,896 posts from the peptide communities across Reddit, X, and PubMed — by what people are actually discussing, and which compounds dominate. The single biggest finding: the community is researching the next GLP-1 before it's approved.
Medically reviewed by Marko Maal, MSc Pharmacy · Source: the live community-signal feed
The takeaways
Key findings
- 1GLP-1s own the conversation — Tirzepatide, Retatrutide and Semaglutide are 3 of the 4 most-discussed compounds.
- 2The community is ahead of the regulator: retatrutide (not FDA-approved) is discussed more than semaglutide (Ozempic/Wegovy), which is.
- 3It's a dosing-and-experience culture — 67% of posts are personal experiences or dosing questions; only 7% are about side effects.
- 4GHK-Cu is the breakout non-GLP-1, the 4th most-discussed compound overall.
- 5Questions outnumber side-effect complaints nearly 2:1 — an information-seeking community, not a venting one.
Post intent
What the community talks about
Every post classified by intent. Two-thirds of the conversation is personal experience and dosing — not side effects or hype.
Most discussed
Top compounds by mention
Mentions across post titles and text. GLP-1s lead — and investigational retatrutide outranks approved semaglutide.
Interpretation
Why it matters
The GLP-1 boom has spilled into a research-peptide community that is now studying the next drug — retatrutide — before approval. That gap between the conversation and the regulation is a genuine public-health and regulatory story.
The conversation is dominated by dosing uncertainty (a third of all posts), underscoring how little authoritative guidance exists for a fast-moving space — and the case for evidence-led, medically-reviewed resources over forum folklore.
Methodology
Posts were collected from public Reddit and X peptide communities and PubMed via public APIs, deduplicated, and each classified by intent (experience, dosing, question, side-effect, research, vendor, regulatory) and by compound mention. Compound counts are mentions across post titles and text; a single post can mention more than one compound. n = 2,896 classified posts (2,719 Reddit, 75 X, 102 PubMed). This is community signal, not clinical evidence — it measures what people discuss, not what works. Explore the live feed at /signal.
Cite this study: “State of the Peptide Community 2026,” My Peptide Story. mypeptidestory.com/signal/state-of-the-peptide-community-2026